Aethlon Medical, Inc. - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
AEMD Nasdaq 3845 https://www.aethlonmedical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aethlon Medical, Inc.

AEMD: Expect Focus on Oncology Studies; Cost Containment Efforts - Nov 16th, 2023 4:06 pm
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript - Nov 16th, 2023 2:35 pm
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update - Nov 14th, 2023 9:15 pm
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer - Nov 13th, 2023 1:01 pm
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 - Nov 6th, 2023 1:01 pm
AEMD: Authorization to Conduct Study in India Moves Oncology Initiatives Ahead - Oct 12th, 2023 2:19 pm
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology - Oct 10th, 2023 12:01 pm
Aethlon Announces Reverse Stock Split - Oct 4th, 2023 12:01 pm
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference - Aug 30th, 2023 12:01 pm
AEMD: Focusing on Oncology, Infectious Disease & Organ Transplants Initially - Aug 14th, 2023 12:03 pm
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update - Aug 10th, 2023 8:15 pm
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023 - Aug 3rd, 2023 12:01 pm
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant - Jul 24th, 2023 12:01 pm
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors - Jul 6th, 2023 6:17 pm
AEMD: Expanding Research Efforts & Strengthening Team, While Minimizing R&D Spending - Jul 6th, 2023 4:10 pm
Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2023 Earnings Call Transcript - Jun 30th, 2023 4:42 pm
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update - Jun 28th, 2023 8:15 pm
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023 - Jun 22nd, 2023 12:01 pm
Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation - Jun 21st, 2023 12:01 pm
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest - Jun 14th, 2023 12:01 pm